Simulations Plus, Inc. (SLP) Stock Price

SLPStock
$18.39+26.29%52W
Market Cap$371.93M
P/E
PEG Ratio9.88
Div yield0.61%
Beta1.32

SLP Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)39.82%
Price vs S&P 500 (4W)-2.67%
PEG Ratio9.88
VGM Score53.02
Indicated Dividend Yield (Annual)0.61%

SLP Earnings Surprise History

Q3 250.10est. 0.12
Q4 250.13est. 0.20
Q1 260.35est. 0.30
Q2 260.30est. 0.23

SLP Analyst Recommendations

May 2026
Jun 2026
Jul 2026
Aug 2026
3.82
3.82
2.50
2.50

Industry Peers — Computer Integrated Systems(60)

SymbolValue ScoreGrowth ScoreMomentum ScorePrice
SLPSimulations Plus, Inc.
DCB$18.39
IOTSamsara Inc.FAB$39.14
IONQIonQ, Inc.FAC$42.05
LDOSLeidos Holdings, Inc.BCC$134.54
QNTQuantinuum Inc. Class A Common StockFF$53.89
CACICACI INTERNATIONAL CLACCB$612.10
GDDYGoDaddy IncCCC$99.79
JKHYHenry (Jack) & AssociatesCCB$173.62
AURAurora Innovation, Inc. Class A Common StockFAC$5.77
OTEXOpen Text CorpBCC$24.36
SAICScience Applications International Corporation Common StockBDB$127.28

About Simulations Plus, Inc.

Simulations Plus develops software for pharmaceutical research and drug development, with its flagship ADMET (Absorption, Distribution, Metabolism, Excretion, and Toxicity) modeling platform serving a core use case in early-stage drug testing. The company generates revenue primarily through software sales, supplemented by consulting and contract research services for pharmaceutical clients. Geographic revenue is concentrated in the United States, with secondary markets in EMEA and Asia Pacific.